These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32477915)

  • 1. Clinical trials using molecular stratification of pediatric brain tumors.
    Hanz SZ; Adeuyan O; Lieberman G; Hennika T
    Transl Pediatr; 2020 Apr; 9(2):144-156. PubMed ID: 32477915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidisciplinary management of childhood brain tumors: a review of outcomes, recent advances, and challenges.
    Pollack IF
    J Neurosurg Pediatr; 2011 Aug; 8(2):135-48. PubMed ID: 21806354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of molecular classification and treatment implications of pediatric brain tumors.
    Guerreiro Stucklin AS; Ramaswamy V; Daniels C; Taylor MD
    Curr Opin Pediatr; 2018 Feb; 30(1):3-9. PubMed ID: 29315108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapy of infantile malignant brain tumors: current status?
    Kalifa C; Grill J
    J Neurooncol; 2005 Dec; 75(3):279-85. PubMed ID: 16195802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatments for astrocytic tumors in children: current and emerging strategies.
    Burzynski SR
    Paediatr Drugs; 2006; 8(3):167-78. PubMed ID: 16774296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric Low-Grade Gliomas.
    Collins KL; Pollack IF
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32375301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood Medulloblastoma: Current Therapies, Emerging Molecular Landscape and Newer Therapeutic Insights.
    Khatua S; Song A; Citla Sridhar D; Mack SC
    Curr Neuropharmacol; 2018; 16(7):1045-1058. PubMed ID: 29189165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric versus Adult Medulloblastoma: Towards a Definition That Goes beyond Age.
    Wooley JR; Penas-Prado M
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medulloblastoma molecular dissection: the way toward targeted therapy.
    Remke M; Ramaswamy V; Taylor MD
    Curr Opin Oncol; 2013 Nov; 25(6):674-81. PubMed ID: 24076581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Grade Gliomas in Children.
    Chalil A; Ramaswamy V
    J Child Neurol; 2016 Mar; 31(4):517-22. PubMed ID: 26286938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular insights into pediatric brain tumors have the potential to transform therapy.
    Gajjar A; Pfister SM; Taylor MD; Gilbertson RJ
    Clin Cancer Res; 2014 Nov; 20(22):5630-40. PubMed ID: 25398846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical Practice.
    Gupta T; Shirsat N; Jalali R
    Curr Pediatr Rev; 2015; 11(2):106-19. PubMed ID: 26133181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations.
    Boisseau W; Euskirchen P; Mokhtari K; Dehais C; Touat M; Hoang-Xuan K; Sanson M; Capelle L; Nouet A; Karachi C; Bielle F; Guégan J; Marie Y; Martin-Duverneuil N; Taillandier L; Rousseau A; Delattre JY; Idbaih A
    Oncologist; 2019 Dec; 24(12):1584-1592. PubMed ID: 31346129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Understanding of BRAF Alterations in Diagnosis, Prognosis, and Therapeutic Targeting in Pediatric Low-Grade Gliomas.
    Penman CL; Faulkner C; Lowis SP; Kurian KM
    Front Oncol; 2015; 5():54. PubMed ID: 25785246
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Li Z; Langhans SA
    Front Oncol; 2021; 11():620831. PubMed ID: 33869004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas.
    Salloum R; McConechy MK; Mikael LG; Fuller C; Drissi R; DeWire M; Nikbakht H; De Jay N; Yang X; Boue D; Chow LML; Finlay JL; Gayden T; Karamchandani J; Hummel TR; Olshefski R; Osorio DS; Stevenson C; Kleinman CL; Majewski J; Fouladi M; Jabado N
    Acta Neuropathol Commun; 2017 Oct; 5(1):78. PubMed ID: 29084603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case-based review: pediatric medulloblastoma.
    Kline CN; Packer RJ; Hwang EI; Raleigh DR; Braunstein S; Raffel C; Bandopadhayay P; Solomon DA; Aboian M; Cha S; Mueller S
    Neurooncol Pract; 2017 Sep; 4(3):138-150. PubMed ID: 29692919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers.
    Korshunov A; Ryzhova M; Hovestadt V; Bender S; Sturm D; Capper D; Meyer J; Schrimpf D; Kool M; Northcott PA; Zheludkova O; Milde T; Witt O; Kulozik AE; Reifenberger G; Jabado N; Perry A; Lichter P; von Deimling A; Pfister SM; Jones DT
    Acta Neuropathol; 2015 May; 129(5):669-78. PubMed ID: 25752754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.